The clinical benefit of IA-tPA for CSO treatment before or after six hours since last seen normal remains unclear, as in other types of stroke from large vessel occlusion in the form of carotid occlusion, it may reduce mortality but not change functional outcome [5,17-18]. This evidence concerns the gene PLAT and stroke disorder.